EFFECTS OF CALCIUM-ANTAGONISTS ON THE HYPERTENSIVE KIDNEY

被引：5
作者：
REAMS, GP
BAUER, JH
机构：
[1] Department of Medicine, Division of Nephrology, Hypertension Section, University of Missouri School of Medicine, Columbia, MO
来源：
CARDIOVASCULAR DRUGS AND THERAPY | 1990年 / 4卷 / 05期
关键词：
calcium antagonists; effective renal plasma flow; glomerular filtration rate; renal function; renal vascular resistance;
D O I：
10.1007/BF02018260
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This review focuses on the effects of calcium antagonists on renal function in hypertensive human subjects. Specifically assessed are the acute and chronic effects of diltiazem, verapamil, amlodipine, felodipine, isradipine, nicardipine, nifedipine, and nitrendipine on glomerular filtration rate; effective renal plasma flow/renal blood flow; renal vascular resistance; and urinary protein excretion. Among the calcium antagonists, only the dihydropyridine derivatives have been demonstrated consistently to acutely increase effective renal plasma flow/renal blood flow. The acute effects on glomerular filtration rate are variable. With respect to chronic therapy, many of the calcium antagonists have been reported to produce sustained increases in the effective renal plasma flow/renal blood flow and/or the glomerular filtration rate. Renal vascular resistance is reduced. Although calcium antagonists preserve or improve renal perfusion and glomerular filtration, long-term clinical trials are required to determine their potential therapeutic benefit to modify the natural course of hypertensive renal disease. © 1990 Kluwer Academic Publishers.
引用
收藏
页码：1331 / 1335
页数：5
相关论文
共 35 条
  • [1] Rea G.P., Lau A., Messina C., Et al., Efficacy, electrocardiographic and renal effects of intravenous diltiazem for essential hypertension, Am J Cardiol, 60, pp. 781-841, (1987)
  • [2] Blackshear J.L., Garnic D., Willia G.H., Et al., Exaggerated renal vasodilator response to calcium entry blockade in first-degree relatives of essential hypertensive subjects, Hypertension, 9, pp. 384-389, (1987)
  • [3] Sakurai T., Kurita T., Nagamo S., Sonoda T., Antihypertensive, vasodilating and sodium diuretic actions of D-cisisomer of benzothiazepine derivative (CRD-401), Acta Urologica Japonica, 18, pp. 695-707, (1972)
  • [4] Tojo S., Shishido H., Yamamoto S., Effects of CRD-401 on blood pressure and renal function, Jpn J Clin Exp Med, 49, pp. 1958-1966, (1972)
  • [5] Sunderrajan S., Rea G.P., Bauer J.H., Renal effects of diltiazem in primary hypertension, Hypertension, 8, pp. 238-242, (1986)
  • [6] Sunderrajan S., Rea G., Bauer J.H., Long-term renal effects of diltiazem in essential hypertension, Am Heart J, 114, pp. 383-388, (1987)
  • [7] Leonetti G., Cuspidi C., Sampieri L., Et al., Comparison of cardiovascular, renal and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects, J Cardiovasc Pharmacol, 4, pp. S319-S324, (1982)
  • [8] Leonetti G., Sala C., Bianchini C., Et al., Antihypertensive and renal effects of orally administered verapamil, Eur J Clin Pharmacol, 18, pp. 375-382, (1980)
  • [9] deLeeuw P.W., Birkenhager W.H., Effects of verapamil in hypertensive patients, Acta Med Scand, 681, pp. 125-128, (1984)
  • [10] Sorenson S.S., Thoen O., Danielsen H., Pedersen E.B., Effect of verapamil on renal plasma flow, glomerular filtration rate and plasma angiotensin II, aldosterone and arginine vasopressin in essential hypertension, Eur J Clin Pharmacol, 29, pp. 257-261, (1985)
1234